Finn Thorup Sellebjerg

Finn Thorup Sellebjerg

Clinical Professor

Member of:

  • Neurology


  1. 2024
  2. E-pub ahead of print

    Extended interval dosing with ocrelizumab in multiple sclerosis

    Novak, F., Bajwa, H. M., Østergaard, K., Berg, J. M., Madsen, J. S., Olsen, D. A., Urbonaviciute, I., Illes, Z., Stilund, M. L., Christensen, J. R., Bramow, S., Sellebjerg, Finn Thorup & Sejbaek, T., 22 Apr 2024, (E-pub ahead of print) In: Multiple Sclerosis Journal. 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    CD11c+ B cells in relapsing–remitting multiple sclerosis and effects of anti-CD20 therapy

    El Mahdaoui, S., Hansen, M. M., von Essen, Marina Rode, Hvalkof, V. H., Hansen, R. H., Mahler, M. R., Jennum, Poul, Sellebjerg, Finn Thorup & Christensen, J. R., 2024, In: Annals of Clinical and Translational Neurology. 11, 4, p. 926-937 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Mortality of the Danish Nationwide AQP4 Antibody-Seropositive Neuromyelitis Optica Spectrum Disorder Patient Cohort

    Papp, V., Magyari, M., Møller, Søren, Sellebjerg, Finn Thorup, Fredriksen, Jette Lautrup, Svendsen, K. B., Søndergaard, H. B., Nilsson, A. C. & Illes, Z., 2024, In: Neurology. 102, 5, 10 p., e209147.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine

    Holm Hansen, R., von Essen, Marina Rode, Reith Mahler, M., Cobanovic, S. & Sellebjerg, Finn Thorup, 2024, In: Frontiers in Immunology. 15, 13 p., 1327672.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Accepted/In press

    Torben Fog – A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research

    Sørensen, Per Soelberg, Bramow, S., Magyari, M., Werdelin, L., Koch-Henriksen, N., Vermersch, P. & Sellebjerg, Finn Thorup, 2024, (Accepted/In press) In: Multiple Sclerosis Journal. 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 923247